Nitric Oxide Test Market Growth Rate, Top Companies, Key Regions

Posted by vinit sawant on April 5th, 2021

Market Highlights

Nitric oxide test measures the level of nitric oxide gas in the sample of exhaled breath, and the results are indicated by the change in the color of the test strip. Nitric oxide test strips and nitric oxide monitors are the most widely used devices to diagnose various respiratory diseases. The test is found to be quite familiar to the population living in developed countries than in the developing and underdeveloped regions across the world.

Increasing prevalence of respiratory diseases, availability of wide range of products for the diagnosis, and treatment of asthma, chronic obstructive pulmonary disease, as well as other lung disorders drive the market. 

The global Nitric Oxide Test size is expected to grow at a CAGR of 5.4% during the forecast period.

Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Nitric oxide test market research report–Global forecast till 2023.”

Major Players in the Market:

Some of the key players in the global market are BERKELEY TEST LIMITED (U.K), Human Power of N, Co. (U.K), ATP Nutritionals LLC (U.S.), Neogenis (U.S.), CVS Health (U.S.), and Uniscience (U.S.).

Regional Analysis

The Americas account for the largest share of the global nitric oxide test strip market owing to the rising demand for medical devices and instruments in healthcare institutes and diagnostics laboratories.

Increasing efforts from asthma management by healthcare providers and government through surveillance at national and state levels are also boosting the growth of the market. As per the Centers for Disease Control and Prevention (CDC) in 2015, 24,633 people were diagnosed with asthma and the number has increased over past few years.

Europe is the second largest market owing to an increasing focus on lung disorder, increasing adoption of home care, and extensive research on asthma, chronic obstructive pulmonary disease, and their prevalence in European countries.